Benitec Biopharma Limited

(BNTC) Trade

By |

Profile

Benitec Biopharma Ltd is active in the healthcare domain. The company is engaged in commercialization of its Intellectual Property, It focusses on development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, deoxyribonucleic acid directed ribonucleic acid interference.

Contact Information

Website: www.benitec.com
Main Phone: +61 295556986
Address: 99 Mount Street
Address 2: Suite 1201
State: NSW
City / Town: Sydney
Country: AUS
Postal Code: 2060

Issuer Information

Exchange: NSC
CEO: Jerel A. Banks
Employees: 15
NAICS: Biological Produ
$ 1.87 $ 0.0409 (2.24%)
Last Price 1.87 Change $ 0.0409 Change % 2.24 Tick N/A
Bid 0.10 Bid Size 1,000.00 Ask 2.22 Ask Size 300.00
Open 1.83 High 1.89 Low 1.83 Prev Close 1.83
Last Trade Volume 2,524 52 Wk Hi 4.90 52 Wk Low 1.78
Market Cap 24 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 12,851,471.00 EPS (TTM) -0.82 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 14 14 14 14
Low Target Price Estimate 14 14 14 14
Mean Target Price Estimate 14 14 14 14
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 02/24/16 02/24/16 02/24/16 02/24/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3